Patent details

Basic Information

Publication number:

EP1631569

PCT Application Number:

PCT/EP/2004/004605

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047305198

PCT Publication Number:

WO/2004/096800

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUINUCLIDINE DERIVATIVES BINDING TO MUCARINIC M3 RECEPTORS

French Title of Invention:

DÉRIVÉS DE QUINUCLIDINE QUI LIENT AUX RÉCÉPTEURS MUSCARINIQUES M3

German Title of Invention:

QUINUCLIDIN-DERIVATE BINDEND AN MUSCARIN-M3-REZEPTOREN

SPC Number:

Dates

Filing date:

30/04/2004

Grant date:

26/08/2009

EP Publication Date:

26/08/2009

PCT Publication Date:

11/11/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/03/2006

EP B1 Publication Date:

26/08/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/04/2012

Expiration date:

30/04/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/04/2004

 

 

Name:

NOVARTIS AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

Collingwood Stephen Paul

Address:

United Kingdom (GB)

2

Name:

Cox Brian

Address:

United Kingdom (GB)

3

Name:

Bhalay Gurdip

Address:

United Kingdom (GB)

4

Name:

Devereux Nicholas James

Address:

United Kingdom (GB)

5

Name:

Baettig Urs

Address:

United Kingdom (GB)

Priority

1

Priority Number:

0310232

Priority Date:

02/05/2003

Priority Country:

United Kingdom (GB)

2

Priority Number:

0324887

Priority Date:

24/10/2003

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 453/02;

Filing date	Document type	Number of pages